Intelligent Bio Solutions Inc.INBSNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank76
5Y CAGR-8.7%
Year-over-Year Change
Year-over-year operating cash flow growth rate
5Y CAGR
-8.7%/yr
Long-term compound
Percentile
P76
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 44.94% |
| Q3 2025 | -28.82% |
| Q2 2025 | 19.80% |
| Q1 2025 | -18.52% |
| Q4 2024 | 2.62% |
| Q3 2024 | 18.91% |
| Q2 2024 | -20.33% |
| Q1 2024 | 14.73% |
| Q4 2023 | -118.71% |
| Q3 2023 | -124.50% |
| Q2 2023 | 76.80% |
| Q1 2023 | -5.78% |
| Q4 2022 | -25.72% |
| Q3 2022 | -9.90% |
| Q2 2022 | -476.12% |
| Q1 2022 | 79.02% |
| Q4 2021 | -1818.34% |
| Q3 2021 | 104.93% |
| Q2 2021 | 72.68% |
| Q1 2021 | -692.75% |
| Q4 2020 | 70.98% |
| Q3 2020 | -1473.13% |
| Q2 2020 | 187.80% |
| Q1 2020 | 52.12% |
| Q4 2019 | 91.68% |
| Q3 2019 | -40.31% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | -135.04% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |